A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (Xclair™), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis

Cutaneous and Ocular Toxicology

Volumn 25, Issue 3, 2006, Pages 165-171

  Primavera, G ^a   Carrera, M ^a   Berardesca, E ^a,c   Pinnaro P ^b   Messina, M ^b   Arcangeli, G ^b  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c NONE   (Italy)

Author keywords

Breast cancer; Dermatitis; MAS065D; Radiotherapy; Xclair

Indexed keywords

ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; HYALURONIC ACID; MAS 065D; UNCLASSIFIED DRUG; XCLAIR;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST CANCER; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; PAIN; PATIENT MONITORING; PRURITUS; RADIATION DERMATITIS; RANDOMIZED CONTROLLED TRIAL; SKIN EXAMINATION; SKIN WATER LOSS; TREATMENT DURATION; TREATMENT OUTCOME;

BREAST NEOPLASMS; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GLYCYRRHETINIC ACID; HUMANS; HYALURONIC ACID; MIDDLE AGED; RADIODERMATITIS; RADIOTHERAPY; SKIN; TREATMENT OUTCOME;

EID: 33748765521     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520600860009     Document Type: Article

References (18)

1. King KB, Nail LM, Kreamer K, Strohl RA, Johnson JE. Patients' descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 1985; 12:55-61.
2. Sivan V, Vozenin-Brotons MC, Tricaud Y, Lefaix JL, Cosset JM, Dubray B, Martin MT. Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy. Int J Radiat Oncol Biol Phys 2002; 53:385-393.
3. Border WA, Noble NA. Transforming growth factor b in tissue fibrosis. N Engl J Med 1994; 19:1286-1289.
4. Schmuth M, Sztankay A, Weinlich G, Wimmer MA, Hofer S, Linder DM, Elias PM, Fritsch PO, Fritsch E. Permeability barrier function of skin exposed to ionizing radiation. Arch Dermatol 2001; 137:1019-1023.
5. Munro AJ, Biruls R, Griffin AV, Thomas H, Vallis KA. et al. Distress associated with radiotherapy for malignant disease: a quantitative analysis based on patients' perceptions. Br J Cancer 1989; 60:370-374.
6. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Morre RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation induced skin toxicity. Int J Radiat Oncol Biol Phys 1996; 36:345-349.
7. Skin care during radiotherapy for breast cancer: a summary of key research findings. Australia: National Breast Cancer Centre, May 2004.
8. Best Practice Statement April 2004: Skincare of Patients Receiving Radiotherapy; Scotland NHS Quality Improvement.
9. Weindl G, Schaller M, Schafer-Korting M, Korting HC. Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol 2004; Sep-Oct; 17(5):207-213.
10. Munro AJ, Parry JM. Ninewells Hospital and Medical School, Dundee. Study to determine the effect of cream applied to the patient's skin during Radiotherapy treatment, on the radiation dose delivered to the target volume, February 17, 2003 (data on file, Sinclair Pharmaceuticals).
11. Calsini P, Barbacci P, Perri F, Sharifian J. "In vitro" effects of telmesteine on scavenger pathway of alveolar macrophages and peripheral blood monocytes. Riv Tub Malat App Resp 1992; XXIV (Fasc.4°):259-265.
12. Maffei Facino R, Carini M, Aldini G, Bombardell E., Morazzoni P, Morelli R. Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis Vinifera. A mechanism for their capillary protective action. Arzneimittel-Forschung 1994; 44(5):592-601.
13. Zafirov D, Bredy-Dobreva G, Lichtev V, Papasova M. Antiexudative and capillaritonic effects of procyanidines isolated from grape seeds (V. Vinifera). Bulgarian academy of sciences. Acta Physiol Pharmacol Bulg 1990; 16:50-53.
14. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes 2002; 110:257-261.
15. Amagaya S, Sugishita E, Ogihara Y, Okada K, Aizawa T. Comaparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities. J Pharmacobiodyn 1984 Dec; 7:923-928.
16. Bomabardelli E, Curri SB, Della Loggia R, Del Negro P, Tubaro A, Gariboldi P. Anti-inflammatory activity of 18-β-glycyrrhetinic acid in Phytosome® form. Fitoterapia 1989; 60:29-37.
17. NCI Common Toxicity Criteria (CTC), Version 2.0 (1/30/98).
18. Diffey BL, Farr PM. A portable instrument for quantifying erythema induced by ultraviolet radiation. Br J Dermatol 1984; 111:663-672.